Keywords:
Genital / Reproductive system male, Nuclear medicine, Oncology, PET-CT, Molecular imaging, Cancer, Metastases
Authors:
L. Saule, M. Radzina, M. Liepa, A. Lioznovs, L. Roznere, L. Zemniece, M. Kalnina, E. Mamis, E. Vjaters
DOI:
10.26044/ecr2022/C-17749
References
1 - Rowe SP, Macura KJ, Mena E, et al. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Mol Imaging Biol. 2016;18(3):411-419. doi:10.1007/s11307-016-0957-6
2-Radzina M, Tirane M, Roznere L, Zemniece L, Dronka L, Kalnina M, Mamis E, Biederer J, Lietuvietis V, Freimanis A, Vjaters E. Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer. Am J Nucl Med Mol Imaging. 2020 Apr 15;10(2):106-118. PMID: 32419979; PMCID: PMC7218697.
3- Paddubny K, Freitag MT, Kratochwil C, Koerber S, Radtke JP, Sakovich R, Kopka K, Giesel FL. Fluorine-18 Prostate-specific Membrane Antigen-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Diagnostics of Local Recurrence in a Prostate Cancer Patient After Recent Radical Prostatectomy. Clin Genitourin Cancer. 2018 Apr;16(2):103-105. doi: 10.1016/j.clgc.2017.09.014.
4 - Saule L, Radzina M, Liepa M, Roznere L, Kalnina M, Lioznovs A, Mamis E, Mikelsone M, Biederer J, Vjaters E. Diagnostic scope of 18F-PSMA-1007 PET/CT: comparison with multiparametric MRI and bone scintigraphy for the assessment of early prostate cancer recurrence. Am J Nucl Med Mol Imaging. 2021 Oct 15;11(5):395-405. PMID: 34754610; PMCID: PMC8569331.